209 related articles for article (PubMed ID: 37483592)
1. Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma.
Wang Z; Tao P; Fan P; Wang J; Rong T; Hou Y; Zhou Y; Lu W; Hong L; Ma L; Zhang Y; Tong H
Front Immunol; 2023; 14():1209396. PubMed ID: 37483592
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
3. Identification of NINJ1 as a novel prognostic predictor for retroperitoneal liposarcoma.
Zhao Y; Qin D; Li X; Wang T; Zhang T; Rao X; Min L; Wan Z; Luo C; Xiao M
Discov Oncol; 2024 May; 15(1):155. PubMed ID: 38733554
[TBL] [Abstract][Full Text] [Related]
4. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.
Li Y; Wu G; Zhang Y; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Zhong H; Fan D; Hong L
Front Oncol; 2022; 12():857827. PubMed ID: 35719991
[TBL] [Abstract][Full Text] [Related]
6. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
9. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
[TBL] [Abstract][Full Text] [Related]
10. Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing.
Zhao S; Ji W; Shen Y; Fan Y; Huang H; Huang J; Lai G; Yuan K; Cheng C
BMC Cancer; 2022 Dec; 22(1):1274. PubMed ID: 36474171
[TBL] [Abstract][Full Text] [Related]
11. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
12. A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.
Ye Z; Zou S; Niu Z; Xu Z; Hu Y
Front Cell Dev Biol; 2021; 9():691676. PubMed ID: 34195202
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
14. Identification of predictors for short-term recurrence: comprehensive analysis of 296 retroperitoneal liposarcoma cases.
Yu Z; Li R; Yuan Z; Ye J; He P; Li P; Sun Y; Zhao X
World J Surg Oncol; 2024 Feb; 22(1):46. PubMed ID: 38321480
[TBL] [Abstract][Full Text] [Related]
15. Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.
Dai J; Li Q; Quan J; Webb G; Liu J; Gao K
BMC Med Genomics; 2023 May; 16(1):93. PubMed ID: 37138287
[TBL] [Abstract][Full Text] [Related]
16. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm.
He X; Feng W
Mediators Inflamm; 2023; 2023():6845701. PubMed ID: 37144238
[TBL] [Abstract][Full Text] [Related]
18. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
19. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]